I don’t have live browsing in this chat, so I can’t pull today’s 2025 headlines directly. If you want real-time news, I can fetch it for you if you enable browsing, or I can guide you to reliable sources to check now. In the meantime, here’s a practical update on AI drug discovery news themes and how to stay current in 2025.
What to look for in AI drug discovery news (2025 themes)
- De novo molecular design advances: diffusion models, graph neural networks, and scaffold-hopping methods accelerating generation of drug-like molecules.
- AI + structure biology integration: use of AlphaFold/structure prediction in conjunction with generative models to prioritize designs with favorable binding and developability.
- Multi-omics and data-fusion: AI pipelines that combine genomics, proteomics, metabolomics, and phenotypic screens to improve target prioritization and safety profiling.
- Safety, ADME/toxicity prediction: improved in silico toxicity and PK/ADME scoring to reduce late-stage failures.
- AI-enabled hit-to-lead and lead optimization: more automated, end-to-end pipelines from target to optimized candidates with speed and traceability.
- Clinical and regulatory evolution: new guidance or case studies on how AI-discovered or AI-augmented programs are progressing through trials; emphasis on model validation, reproducibility, and explainability.
- Industry activity and funding: partnerships between big pharma and AI startups; more equity investments and licensing deals; consortia around AI for drug discovery.
- Tools and platforms: updates from Exscientia, Insilico Medicine, Schrödinger, Atomwise, BenevolentAI, Relay Therapeutics, Relay Therapeutics (AI in structural biology), Bay Labs, and academic collaborations.
Where to check today (reliable sources)
- High-impact journals: Nature Medicine, Nature Biotechnology, Science, Cell, Nature Machine Intelligence, Journal of Chemical Information and Modeling (JCIM).
- Trade and analysis outlets: Endpoints News, FierceBiotech, BioPharma Dive, Pharmaceutical Technology, BioCentury.
- General science outlets often publish AI drug discovery stories: TechCrunch (startup activity), STAT News.
- PubMed and arXiv for cutting-edge papers: search terms like “AI drug discovery 2025,” “AI de novo design,” “diffusion models in medicinal chemistry,” “AlphaFold docking AI.”
- Company blogs and press releases from major players: Exscientia, Insilico Medicine, Schrödinger, Atomwise, Evotec, Relay Therapeutics, BridgeBio, and others.
If you’d like, I can:
- Summarize notable topics or papers from 2023–2024 and discuss what to expect in 2025.
- Provide a customizable daily/weekly digest template (e.g., hit discovery, design optimization, safety AI, regulatory updates).
- Help you build a tailored search strategy (specific keywords, journals, and alert sources) to keep you updated in real time.
Would you like me to:
- fetch and summarize today's headlines if you enable browsing, or
- give a concise 2024–2025 trend snapshot with example companies and technologies, or
- assemble a ready-to-use list of links and search queries you can check now?